French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced its acquisition of UK-based biotech firm Vicebio in a deal ...

French pharma major Sanofi today announced it has entered into an agreement to acquire Vicebio, a privately held biotechnology company headquartered in London, UK.

Dutch privately-held biotech Kling Bio today announced it has entered into a collaboration and license option agreement with French pharma major Sanofi for the discovery of antibodies and epitopes ...

A strategic milestone for the capital to strengthen global health security, ensure equitable vaccine access and build resilient supply chains ...

Vietnam has made remarkable progress in protecting children from vaccine-preventable diseases, according to the latest World ...

With four approved indications globally, including two in the front-line setting, the approval further affirms Sarclisa as an established MM treatment option, reflecting Sanofi’s ambition to address ...

On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' ...

Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive aren't actually so.

The US Securities and Exchange Commission has subpoenaed information from Telix, in relation to the company's therapeutic ...

The pharmaceutical company is accelerating its expansion in the country as President Donald Trump considers tariffs of up to ...

The design of recruitment tools for clinical trials impacts rates of enrollment, with higher enrollment seen for shorter letters.